Exploring Next Generation Solutions for Urologic Illnesses
About NMARG
Impacting Patient Outcomes
I'm a paragraph. Click here to add your own text and edit me. Let your users get to know you.
Disease Advocacy and Awareness
I'm a paragraph. Click here to add your own text and edit me. Let your users get to know you.
Collaborative
Networking
I'm a paragraph. Click here to add your own text and edit me. Let your users get to know you.
Pioneering Research Initiatives
I'm a paragraph. Click here to add your own text and edit me. Let your users get to know you.
Prostate cancer is one of the most common cancers affecting men in the United States, with approximately 1 in 8 men diagnosed during their lifetime. It primarily impacts older individuals, with the majority of cases found in men aged 65 and older.
​
At the forefront of addressing these challenges, the National Medical Association and Research Group (NMARG) studies cutting-edge technologies to improve the prognosis and treatment of prostate cancer and other urologic illnesses.
From artificial intelligence integrated imaging techniques to personalized medicine approaches, NMARG's research aims to transform patient care and enhance long-term outcomes.
We Take Pride in Our Performance
25+
Years of Experience
~100k
Patients Served
15
Publications
5
Business Partners
10
Industry Awards